De Novo Donor Specific Antibody Expression in Lung Transplant Recipients with EVLP-Conditioned Allografts

被引：0
|
作者：
Trindade, A. J. [1 ]
Stokes, J. W. [2 ]
Gannon, W. D. [1 ]
Chapin, K. C. [3 ]
Lambright, E. S. [2 ]
McPherson, K. A. [1 ]
Norfolk, S. G. [1 ]
Robbins, I. M. [1 ]
Shaver, C. M. [1 ]
Bacchetta, M. [2 ]
机构：
[1] Vanderbilt Univ, Allergy Pulm & Crit Care Med, Med Ctr, Nashville, TN USA
[2] Vanderbilt Univ, Thorac Surg, Med Ctr, Nashville, TN USA
[3] Vanderbilt Univ, Med Ctr, Nashville, TN USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2022年 / 41卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
688
引用
收藏
页码：S288 / S289
页数：2
相关论文
共 50 条
  • [1] De Novo Donor-Specific Antibody Development with Mycophenolate versus Azathioprine in Lung Transplant Recipients.
    Prom, A.
    Walter, K.
    Gomez, K.
    Doligalski, C.
    Lobo, L.
    Evans, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 481 - 482
  • [2] FAST DE NOVO DONOR SPECIFIC ANTIBODY DEVELOPMENT IN LUNG TRANSPLANT RECIPIENT
    Lobashevsky, Andrew L.
    Rosner, Kevin M.
    May, John
    Roe, David
    Duncan, Michael
    Hage, Chadi
    Lushin, Erin
    Anderson, Eve
    HUMAN IMMUNOLOGY, 2016, 77 : 135 - 136
  • [3] Association between Respiratory Virus Infection and Development of De Novo Donor-Specific Antibody in Lung Transplant Recipients
    Nellore, Anoma
    Houp, Julie
    Killian, John T.
    Limaye, Ajit P.
    Fisher, Cynthia E.
    VIRUSES-BASEL, 2024, 16 (10):
  • [4] Carfilzomib versus Rituximab for Treatment of De Novo Donor Specific Antibodies in Lung Transplant Recipients
    Razia, D.
    Hu, C.
    Cherrier, L.
    Nasar, A.
    Walia, R.
    Tokman, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S112 - S113
  • [5] Is COVID Vaccine Associated with Development of De Novo Donor Specific Antibodies in Lung Transplant Recipients?
    Nandavaram, S.
    Benninger, L.
    Scheuble, V.
    Chandrashekaran, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S158 - S159
  • [6] Incidence of De Novo Donor Specific Antibodies in Kidney Transplant Recipients
    Staino, C.
    Pilch, N.
    Moussa, O.
    Boyle, K.
    Casale, J.
    Covert, K.
    Fleming, J.
    Taber, D.
    Meadows, H.
    Mardis, C.
    Chavin, K.
    Nadig, S.
    McGillicuddy, J.
    Bratton, C.
    Srinivas, T.
    Baliga, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [7] Elevated de novo donor specific antibody after alemtuzumab induction in renal transplant recipients.
    Jorgenson, Margaret
    Fose, Jillian
    Redfield, Robert
    Fabbri, Kassandra
    PHARMACOTHERAPY, 2016, 36 (07): : E103 - E104
  • [8] COMPARISON OF DE NOVO DONOR SPECIFIC ANTIBODY FORMATION FOR KIDNEY TRANSPLANT RECIPIENTS INDUCED WITH THYMOGLOBULIN OR BASILIXIMAB
    Qazi, Yasir
    Gong, Alex
    Lee, Kristina
    Smogorzewski, Mirosolaw
    TRANSPLANT INTERNATIONAL, 2017, 30 : 531 - 531
  • [9] Elevated De Novo Donor Specific Antibody After Alemtuzumab Induction in Renal Transplant Recipients.
    Fabbri, K.
    Descourouez, J.
    Jorgenson, M.
    Redfield, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 619 - 619
  • [10] CLINICAL SIGNIFICANCE OF DE NOVO DONOR SPECIFIC ANTIBODY IN KIDNEY TRANSPLANT RECIPIENTS WITH CHRONIC ANTIBODY-MEDIATED REJECTION
    Park, Woo Yeong
    Paek, Jin Hyuk
    Jin, Kyubok
    Park, Sung Bae
    Han, Seungyeup
    TRANSPLANT INTERNATIONAL, 2019, 32 : 102 - 102
12345